Conferences - Results from #100

Viewing 101-120 of 11872 articles

SCS AUA 2024: Does the Use of Continuous Bladder Irrigation After TURBT Increase the Risk of Complications?

SCS AUA 2024: Should Veterans be Classified as High Risk for Prostate Cancer Screening: A Review of the Current Literature

SCS AUA 2024: Can the PSMA PET SUVmax Predict High Risk Pathology and High Risk Disease? A Single Center Prospective Disease

SCS AUA 2024: Elucidating the Response Rates to Additional BCG: Implications for Clinical Trial Design

SCS AUA 2024: Can We Predict Locally Advanced Disease Features with PSMA PET? Correlation of Molecular Imaging TNM with Pathological TNM in Radical Prostatectomy Specimen

SCS AUA 2024: Real-World Treatments Following BCG Induction in Patients with NMIBC: A Contemporary US Claims Analysis

SCS AUA 2024: Urothelial Carcinoma of the Prostate and Intravesical Therapy: A Cautionary Tale

SCS AUA 2024: Nephron Sparing Surgery for Localized Renal Masses

SCS AUA 2024: Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

SCS AUA 2024: Efficacy of Intravesical Nadofaragene Firadenovec-VNCG for Patients with BCG-Unresponsive NMIBC: 36-Month Follow-Up from a Phase 3 Trial

SCS AUA 2024: Case Discussion: Management of Localized Renal Masses in Younger Patients and Patients with Heritable Kidney Cancer Syndromes

SCS AUA 2024: Adjuvant Immunotherapy in High-Risk Muscle Invasive Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

SCS AUA 2024: Bladder Cancer Recurrence Analysis in Veterans and Outcomes (BRAVO): White Light Versus Blue Light Cystoscopy Outcomes Among NMIBC Patients in an Equal Access Setting

SCS AUA 2024: Exposures and Bladder Cancer Risk Among Military Veterans: A Systemic Review and Meta-Analysis

SCS AUA 2024: Indications and Outcomes for Ablation Therapy in Renal Masses

SCS AUA 2024: Indications and Outcomes for Radiation Therapy in Renal Masses

SCS AUA 2024: High Risk NMIBC Treatment: The Case for Radical Cystectomy

SCS AUA 2024: High Risk NMIBC Treatment: The Case for Bladder Sparing Therapy

SCS AUA 2024: The Top 10 Reasons Why BCG (as a Monotherapy) Will Cease to Exist

SCS AUA 2024: BCG Will Always Be the First Line: Yes

1
2
3
4
5
6
7
8
9
10